Aktia Capital B - Fondmarknaden

Fondinnehav - Finland Aktie T - Danske Invest

The Revenio Group comprises Revenio Group Oyj, Icare Finland Oy, Icare USA Inc., Revenio Italy S. R. L, CenterVue SpA, Revenio Research Oy, Done Medical Oy and Oscare Medical Oy. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V. E-mail addresses: info(at)revenio.fi. Investor contacts. CEO Jouni Toijala jouni.toijala(at)revenio.fi. CFO Robin Pulkkinen robin.pulkkinen(at)revenio.fi.

Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Revenio Group Oyj on perustettu vuonna 2001. Se on julkinen osakeyhtiö, jonka kotipaikka on Vantaa, ja pääasiallinen toimiala Holding-yhtiö. Yhtiön toimitusjohtaja on Jouni Erik Toijala. Yhtiön Revenio Group Oyj liikevaihto oli 744 tuhatta ja tilikauden tulos 13,66 miljoonaa. Revenio is a Finnish health tech group whose core business is tonometers. The Revenio Health Tech segment comprises the business operations of Icare Finland Oy. The widely patented Icare product family is the current cornerstone of the Group’s success.

Tilikauden tulos oli -1,9 miljoonaa euroa ja liikevoittoprosentti oli -402,4 %. Yhtiön omavaraisuusaste oli 72 %. Y-tunnus 1700625-7 Maa Suomi Postiosoite Äyritie 22, 01510 Vantaa Toimiala Revenio Group Oyj, pörssitiedote, 16.3.2020 klo 16.00.

Revenio Group Aktiespararna

Nordnetissä voit käydä kauppaa edullisin hinnoin. Klikkaa tästä ja katso reaaliaikainen osakekurssi.

Revenio Group Aktiespararna

Timo has 9 jobs listed on their profile. See the complete profile on LinkedIn and discover Timo’s The Revenio Group consists of Icare Finland Oy, Icare USA Inc., Revenio Italy S.R.L, CenterVue SpA, Revenio Research Oy, Done Medical Oy and Oscare Medical Oy. The common denominators of Revenio's business operations include patient-oriented screening, follow-up and the global need to make cost savings through preventive health care. The Revenio Group consists of Icare Finland Oy, Revenio Research Oy and Oscare Medical Oy, in which Revenio holds a 53.5% interest. The common denominators of Revenio's business operations include screening, follow-up and the global need to make cost savings through preventive health care.

Revenio is a Finnish health tech group whose core business is tonometers. The Revenio Health Tech segment comprises the business operations of Icare Finland Oy. The widely patented Icare product family is the current cornerstone of the Group’s success. Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment.
Knäskydd arbete test

Revenio Research puolestaan keskittyy ihosyövän ja astman diagnosointia ja hoidon suunnittelua tukevien järjestelmien kaupallistamiseen. Revenio-konsernin liikevaihto vuonna 2019 oli 49,5 miljoonaa euroa ja liikevoitto 25,5 %. Revenio Group Oyj on listattu Nasdaq Helsinki Oy:ssä. Revenio Group Oyj, Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others. Revenio Research puolestaan keskittyy ihosyövän ja astman diagnosointia ja hoidon suunnittelua tukevien järjestelmien kaupallistamiseen.

3.2 %. Revenio Group Oyj. 2.9 %. Brodrene Hartmann.
Lediga jobb hässleholm lokalvårdare

rickshaw taxi bangor maine
kemicentrum housing
köksmästaren stockholm
rizzo group stockholm
index 400-011
healthmanager5 login

Aktia Nordic Small Cap B - Fondmarknaden

Revenio Group Oyj:n hallitus on päättänyt käyttää 20.3.2019 pidetyn yhtiökokouksen antamaa valtuutusta hankkia omia osakkeita ja perustaa osakkeiden takaisinosto-ohjelman. Revenio-konserniin kuuluvat Icare Finland Oy, Revenio Research Oy sekä Oscare Medical Oy. Revenion liiketoiminnan ydin on kehittää ja kaupallistaa tehokkaita ja helposti käyttöönotettavia glaukooman diagnoostiikkaa ja hoidon aikaista seurantaa avustavia laitteita. Revenio tavoittelee terveysteknologiassa voimakasta kasvua. Revenio Group Corporation Stock Exchange Release, October 29, 3:30 p.m.

Valuta myr eur
key account manager media

ELN, Ellen, SE0014730347 - Nasdaq

Revenio Group Corporation has increased its ownership in Oscare Medical Oy to 53% on December 4, 2013. Owning the majority of Oscare Medical fits Revenio’s strategic objective to expand their health technology segment. The objective is to offer health care professionals an … Revenio Group Corporation Stock Exchange Release, October 29, 3:30 p.m. NOTICE PURSUANT TO SECTION 9, CHAPTER 2 OF THE SECURITIES MARKET ACT Revenio Group Corporation has received a notice that the shareholding of Eyemaker's Finland Oy in Revenio Group Corporation has decreased to less than one tenth (1/10) of the shares and the voting rights of Revenio Group Corporation. The Revenio Group comprises Revenio Group Oyj, Icare Finland Oy, Icare USA Inc., Revenio Italy S. R. L, CenterVue SpA, Revenio Research Oy, Done Medical Oy and Oscare Medical Oy. In 2019, the Group's net sales totalled EUR 49.5 million, with its operating profit standing at 25.5%.

Sök Aktier Helsingfors Stockholm Köpenhamn Iceland OMX

Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Köp aktier i Revenio Group Oyj - enkelt och billigt hos Avanza Bank. HeliAsema: Muu ylin johto(X) OikeushenkilöLiikkeeseenlaskija: Revenio Group Oy. Kauppalehden yritystietopalvelusta löydät yrityksen Revenio Group Oyj taloustiedot, perustiedot, liikevaihdon ja rekisteritiedot. Klikkaa ja tutustu! Revenio Group Corporation, Stock Exchange Release, March 19, 2021 at 9.00 EET. Revenio acquires Oculo and strengthens its expertise in clinical eye care Group comprises Revenio Group Corporation, Icare Finland Oy, Icare USA Inc.,. Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Osta osaketta Revenio Group Corporation (REG1V).

Yhtiön Revenio Group Oyj liikevaihto oli 744 tuhatta ja tilikauden tulos 13,66 miljoonaa. Revenio Group Oyj is a globally operating health technology, which engages in the detection of glaucoma, osteoporosis, skin cancer, and asthma. It operates through the Revenio Health Tech segment, Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. About Revenio Group Oyj. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others. Revenio is a Finnish health tech group whose core business is tonometers. The Revenio Health Tech segment comprises the business operations of Icare Finland Oy. The widely patented Icare product family is the current cornerstone of the Group’s success. Pekka Veikko Juhani Rönkä, 67 Chairman: Revenio Group Oyj: Kari-Pekka Sakari Tammela, 57 Independent Director: Pikespo Invest Oy Ltd., Lifa Air Finland Oy, Pj Maa Partners Oy, Revenio Group Oyj Kari-Pekka Sakari Tammela Independent Director, Revenio Group Oyj. Kari-Pekka Sakari Tammela is a businessperson who has been at the head of 7 different companies.